Sage Healthcare and Roth Capital Partners launch European healthcare collaboration

Sage Healthcare and Roth Capital Partners on Oct. 8 announced a collaboration to identify European healthcare and life-science companies that may need transaction advice and U.S. capital markets support. The move links Sage’s European network and AI-enabled analysis with Roth’s healthcare investment banking and financing platform.

Why it matters: - The collaboration is aimed at helping European healthcare and life-science companies access transaction advice and U.S. capital markets expertise. - The pairing could broaden financing and strategic growth options for companies looking beyond their home market.

What happened: - Sage Healthcare Ltd and Roth Capital Partners announced a strategic collaboration on Oct. 8, 2026. - The effort will identify and assess European healthcare and life-science companies that may benefit from transaction advice and U.S. capital markets support. - Sage is based in London. - Roth Capital Partners is based in Newport Beach, California.

The details: - Sage will contribute its European network, transaction experience and SAGEIQ™, an AI-enabled deep market analysis capability. - Roth will provide healthcare investment banking, financing strategy and U.S. capital markets services. - Roth’s role is subject to compliance and client-acceptance procedures. - Sage said it supports licensing, partnering and M&A through its specialist healthcare and life-science advisory work. - Roth said it provides financing and strategic financial advisory services to healthcare growth companies. - More information is available on Sage Healthcare’s website. - More information is available on Roth Capital Partners’ website.

Between the lines: - The collaboration combines European sourcing with U.S. capital markets reach, which can be useful for companies seeking cross-border financing or deal execution. - The use of SAGEIQ suggests Sage is positioning data and market analysis as part of its advisory edge. - The announcement signals a push to pair specialist healthcare advisory capabilities with investment banking distribution.

What's next: - The firms will evaluate relevant opportunities together. - The collaboration will likely focus on companies that fit Roth’s healthcare investment banking and capital markets mandate. - Any transaction work will still depend on Roth’s internal compliance and client review process.

The bottom line: - Sage and Roth are tying together European deal sourcing and U.S. financing expertise to target healthcare and life-science companies with cross-border growth needs.